
|Articles|November 30, 2017
Bioclinica Launches Clinical Adjudication for Enhanced Safety and Efficacy in Clinical Trials
Advertisement
Bioclinica® announced the launch of Bioclinica Clinical Adjudication, an offering in which medical specialists and researchers, backed by technology, lead independent Clinical Event Committee review. The new service enables the independent adjudication of clinical events in conformance with regulatory requirements governing clinical trials within all therapeutic areas. Bioclinica will bring in professionals who specilize in each particular endpoint area and this adjudication will ultimately help manage the complete process.
Read the full release
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Evolution of Preclinical CRO Strategic Partnerships: From Transactional Services to Value-Driven Ecosystems in 2026
2
The Execution Gap: Why Clinical Trial Infrastructure Has to Be Built Before AI Can Deliver
3
What the Epilepsy Community Has Taught Us About Trial Feasibility
4
ACT Brief: Endpoint Selection and Patient Engagement, Execution Infrastructure Before AI, and Real-World Data Quality Gaps
5




